Childhood Non-Hodgkin Lymphoma — Trials

Childhood Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 9
Recruiting: 5
Ph III recruiting: 1
Growth YoY: —
Industry share: 11%
Top sponsor: Children's Cancer Group, China
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05215405	Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL	no longer available	—	—	Kathleen LudwigOTHER	1	Feb 3, 2025	clinicaltrials

Data updated 23 days agoSource updated Feb 3, 2025source: clinicaltrials